Neuronal impairment of adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with Tc-99m HM- PAO: A trial of clinical quantification of metabolites

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 2, 1999, Pages 124-129

  Harada, Masafumi ^a   Miyoshi, Hirokazu ^a   Uno, Masaaki ^a   Okada, Toshiko ^a   Hisaoka, Sonoka ^a   Hori, Ayuko ^a   Nishitani, Hiromu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Concentration; Moyamoya disease; Perfusion; Proton MRS; Quantification

Indexed keywords

CHOLINE; CREATINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MOYAMOYA DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOYAMOYA DISEASE; NEURONS; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M EXAMETAZIME; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032790576     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199908)10:2<124::AID-JMRI3>3.0.CO;2-T     Document Type: Article

References (15)

1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299.
2. Hasuo K, Mihara F, Matsushima T. MRI and MR angiography in moyamoya disease. J Magn Reson Imaging 1998;8:762-766.
3. Barkovich AJ. Moyamoya syndrome. In: Pediatric neuroimaging, 2nd ed. New York: Raven Press; 1995. p 649.
4. Ohashi K, Fernandez-Ulloa M, Hall LC. SPECT, magnetic resonance and angiographic features in a moyamoya patients before and after external-to-internal carotid artery bypass. J Nucl Med 1992;33: 1692-1695.
5. Yamada I, Murata Y, Umehara I, Suzuki S, Matsushima Y. SPECT and MRI evaluations of the posterior circulation in moyamoya disease. J Nucl Med 1996;37:1613-1617.
6. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson Series B 1993;102:9-19.
7. 1H-MRS using water as an internal standard. Magn Reson Imaging 1993;11:107-118.
8. Pouwels PJW, Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 1997;10:73-78.
9. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m hexamethyl-propylene amine oxime. Eur J Nucl Med 1992;19:195-200
10. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. Non-invasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1993;20:391-401.
11. Shimizu H, Shirane R, Fujiwara S, Takahashi A, Yoshimoto T. Proton magnetic resonance spectroscopy in children with moyamoya disease. Clin Neurol Neurosurg 1997;99Suppl2:S64-67
12. Henriksen O, Cady E, Barbiroli B, et al. Comparison of calibration strategies for quantitation of brain metabolite concentrations in multi-center trials - an international proton MRS study. In: Proceedings of the SMR Third Annual Meeting, Nice France, 1995. p 259.
13. 1H-MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 1998;50:1033-1040.
14. 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiol Oncol Biol Phys 1995;33:719-724.
15. Otsuka H, Harada M, Hieda M et al. Magnetic resonance studies of dentato-rubro-pallido-luysian atrophy - correlation with clinical severity and age of onset. No-To-Shinkei 1996;48:818-823.